Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations: 2009-2019

Historic Cash from Discontinued Operations for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2019 value amounting to $11.4 million.

  • Ironwood Pharmaceuticals' Cash from Discontinued Operations was N/A to $11.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $14.3 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2019, which is 3.76% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Cash from Discontinued Operations stood at $11.4 million for FY2019, which was down 3.76% from $11.8 million recorded in FY2018.
  • In the past 5 years, Ironwood Pharmaceuticals' Cash from Discontinued Operations ranged from a high of $11.8 million in FY2018 and a low of $7.3 million during FY2017.
  • For the 3-year period, Ironwood Pharmaceuticals' Cash from Discontinued Operations averaged around $10.2 million, with its median value being $11.4 million (2019).
  • Its Cash from Discontinued Operations has fluctuated over the past 5 years, first surged by 62.04% in 2018, then declined by 3.76% in 2019.
  • Ironwood Pharmaceuticals' Cash from Discontinued Operations (Yearly) stood at $7.3 million in 2017, then soared by 62.04% to $11.8 million in 2018, then decreased by 3.76% to $11.4 million in 2019.